Emphysema is a structural lung disorder defined by abnormal, permanent enlargement of airspaces distal to the terminal bronchioles accompanied by destruction of their walls, with relatively little obvious fibrosis in the classic pathological definition. The destruction reduces the surface area available for gas exchange and disrupts the architecture that normally supports small airways during expiration. Because alveolar walls contain elastic tissue and form part of the pulmonary capillary interface, their loss affects both respiratory mechanics and oxygen transfer.
Emphysema is commonly associated with Chronic Obstructive Pulmonary Disease, but the anatomical term should not be treated as an exact synonym for the clinical diagnosis because emphysema can be present to varying degrees and some people with Chronic Obstructive Pulmonary Disease have relatively little emphysematous destruction. The word derives from Greek roots associated with blowing or inflation and historically referred to abnormal air-filled spaces. Modern imaging and pathology have refined the concept considerably. Clinically important emphysema may remain relatively silent for years before breathlessness becomes prominent, and its manifestations depend on distribution, severity, associated airway disease and individual physiological reserve.
The dominant acquired cause of emphysema is prolonged inhalation of tobacco smoke, which exposes the respiratory tract to oxidants, particulate matter and numerous inflammatory stimuli. Cigarette smoking promotes recruitment and activation of inflammatory cells, release of proteolytic enzymes, oxidative stress and damage to alveolar structures. Occupational and environmental inhalants can also contribute, particularly when exposure is intense or prolonged. A well-established inherited cause is severe alpha-1 antitrypsin deficiency.
Alpha-1 antitrypsin normally inhibits neutrophil elastase and other proteolytic activity in the lung; inadequate protection allows protease-mediated destruction of elastic tissue. Severe deficiency classically produces predominantly lower-lung emphysema at a younger age, whereas smoking-related disease often has a different distribution and develops later, although individual patterns vary. The interaction between genetic susceptibility and smoking is especially important because tobacco exposure substantially increases the risk and severity of emphysema in people with alpha-1 antitrypsin deficiency. Recognition of inherited susceptibility can influence family assessment, exposure avoidance and management, making emphysema an example of how environmental and genetic determinants can converge on the same structural phenotype.
Pathologically, emphysema can be divided into recognised patterns according to which parts of the acinus are preferentially affected. Centriacinar emphysema predominantly affects respiratory bronchioles and is strongly associated with smoking, especially in upper-lung regions. Panacinar emphysema involves more uniform destruction throughout the acinus and is classically associated with alpha-1 antitrypsin deficiency, often with greater lower-lung involvement. Distal acinar emphysema preferentially affects the structures near alveolar ducts and pleural surfaces and can be associated with spontaneous pneumothorax, particularly in younger people.
Irregular emphysema occurs alongside scarring and may be incidentally identified. These pathological categories are not merely academic because distribution can affect symptoms, imaging appearance, physiological impairment and suitability for selected interventions. Destruction of alveolar septa also removes portions of the pulmonary capillary bed, potentially increasing pulmonary vascular resistance. At the same time, loss of elastic recoil reduces the driving pressure for expiration and makes airway closure more likely. The combination explains why emphysema produces both impaired gas exchange and expiratory airflow limitation.
The mechanical consequences of emphysema are central to its clinical manifestations. Healthy lungs possess elastic recoil that helps drive passive expiration and contributes to keeping small airways open. Destruction of alveolar attachments weakens this radial traction, allowing small airways to narrow or collapse during expiration. Air therefore becomes trapped behind partially closed airways, increasing residual volume.
During exercise, when breathing frequency rises and there is less time available for exhalation, dynamic hyperinflation can develop: end-expiratory lung volume rises and progressively limits the volume available for the next inspiration. This produces the characteristic sensation that the person cannot get enough air despite having large total lung volumes. The diaphragm becomes flatter as the chest remains chronically expanded, reducing its mechanical efficiency. Accessory respiratory muscles may consequently contribute more to breathing, increasing energy expenditure. In advanced disease, severe hyperinflation can impair venous return and cardiac filling as well as respiratory mechanics. Thus, emphysema-related breathlessness is not explained solely by low oxygen levels; altered lung mechanics, hyperinflation and increased work of breathing are major determinants.
Computed tomography is particularly useful for identifying and characterising emphysema because areas of destroyed lung have reduced attenuation and can be mapped according to their distribution and extent. Imaging can distinguish broad patterns, identify bullae and help evaluate candidates for selected lung-volume-reduction interventions. Pulmonary function testing can demonstrate airflow obstruction, increased residual volume, increased total lung capacity and reduced diffusing capacity when destruction of the alveolar-capillary surface is substantial.
The degree of anatomical emphysema and physiological impairment does not always correspond exactly, so clinical assessment remains necessary. A reduced diffusing capacity can also occur in other pulmonary disorders and therefore is not diagnostic by itself. Alpha-1 antitrypsin testing is appropriate in relevant clinical contexts and is important because identifying a hereditary deficiency has implications for exposure avoidance and potentially for family members. Chest radiography can show hyperinflation and flattened diaphragms in established disease but is less sensitive than computed tomography for defining emphysema. Functional assessment, exercise testing and oxygen measurements help determine how anatomical changes translate into limitations in daily life.
Management of emphysema aims primarily to stop ongoing lung injury, reduce symptoms and complications, and preserve functional capacity. Smoking cessation is the most important modifiable intervention for smoking-related disease because continued exposure perpetuates inflammation and structural damage. Inhaled bronchodilators can reduce airflow limitation and hyperinflation, particularly when small-airway narrowing contributes significantly to symptoms. Pulmonary rehabilitation can improve exercise performance despite the permanence of structural destruction by improving muscular efficiency, conditioning and strategies for managing exertional breathlessness.
Vaccination, prompt management of exacerbations and treatment of associated Chronic Obstructive Pulmonary Disease are important preventive measures. Nutritional and exercise interventions may be needed because severe emphysema can increase energy expenditure and contribute to muscle wasting. In selected patients with severe heterogeneous emphysema, lung-volume-reduction surgery or bronchoscopic approaches can remove or functionally isolate severely diseased regions, allowing relatively better-preserved lung to operate more efficiently. These interventions require careful physiological and anatomical selection because they are not appropriate for all patients and can carry significant risks.
Severe emphysema can produce chronic respiratory failure, pulmonary hypertension, secondary right-heart dysfunction and marked functional limitation. Bullous disease can create very large air-filled spaces that compress adjacent functional lung and, if a fragile bulla ruptures, can contribute to spontaneous pneumothorax. Oxygen therapy may be indicated for chronic severe hypoxaemia after formal assessment, while transplant evaluation can be considered for selected people with advanced disease and severe impairment.
Alpha-1 antitrypsin deficiency has additional management implications because smoking avoidance is particularly important and specific replacement therapy may be considered for appropriately selected individuals in healthcare systems where it is available. Prognosis varies with smoking exposure, lung function, gas exchange, exercise capacity, exacerbation frequency and comorbid disease. Emphysema can coexist with airway-predominant Chronic Obstructive Pulmonary Disease, and many patients therefore have mixed structural abnormalities rather than a pure emphysema phenotype. Cardiovascular disease, osteoporosis, muscle weakness, anxiety, depression and nutritional problems can materially influence disability. Consequently, anatomical destruction should not be interpreted in isolation from the wider physiological and social consequences of chronic respiratory disease.
A common misconception is that emphysema means simply having "large lungs" or excess air; the defining problem is destruction of alveolar architecture and loss of elastic recoil, with air trapping occurring as a consequence. Another misconception is that emphysema is reversible with inhalers. Bronchodilators can improve airflow, reduce dynamic hyperinflation and relieve symptoms, but they cannot regenerate destroyed alveolar walls.
Emphysema also does not inevitably progress at the same rate in every person, and stopping smoking can substantially alter the trajectory even after structural disease has developed. The condition illustrates an important distinction between anatomical diagnosis and physiological syndrome: emphysema is a pathological pattern, whereas Chronic Obstructive Pulmonary Disease is diagnosed clinically and physiologically through persistent airflow obstruction in the appropriate context.
Modern imaging has made it possible to quantify emphysema distribution and severity, supporting increasingly individualised approaches to prognosis and intervention. Its study has also contributed to understanding protease-antiprotease imbalance, oxidative stress, inflammatory signalling, tissue repair and the mechanical determinants of airflow obstruction, making emphysema important not only as a clinical disease but as a model of chronic structural injury in the respiratory system.
